my account  log out
 

Product Name:Celecoxib

Create: 04/17/2018
Expired Date:never
Category: Methacrylate intermediates [Chemical]
Message:Product Name:Celecoxib Another Name:CELEBREX; 4-[[5-(4-METHYLPHENYL)-3-TRIFLUOROMETHYL]-1H-PYRAZOL-YL]BENZENESULFONAMIDE; 4-[5-((4-METHYLPHENYL)-3-TRIFLUORPMETHYL)-1H-PYRAZOL-YL]BENENESULFONAMIDE; Celecoxib, 4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-yl]benzenesulfonamide; Benzenesulfonamide, 4-5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl-; 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide; Celebra- CAS: Molecular Weight:381.37 Molecular Formula:C17H14F3N3O2S [main adjuvant therapy use] treatment of osteoarthritis, rheumatoid arthritis and familial adenomatous polyposis Another Name:CELEBREX; 4-[[5-(4-METHYLPHENYL)-3-TRIFLUOROMETHYL]-1H-PYRAZOL-YL]BENZENESULFONAMIDE; 4-[5-((4-METHYLPHENYL)-3-TRIFLUORPMETHYL)-1H-PYRAZOL-YL]BENENESULFONAMIDE; Celecoxib, 4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-yl]benzenesulfonamide; Benzenesulfonamide, 4-5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl-; 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide; Celebra- CAS: Molecular Weight:381.37 Molecular Formula:C17H14F3N3O2S [main adjuvant therapy use] treatment of osteoarthritis, rheumatoid arthritis and familial adenomatous polyposis
City:Wuhan Hubei[CN] 
Location:
 
Jun 19 2018 Flunixin meglumin6666612
Jun 19 2018 Flunixin meglumin222214
Jun 19 2018 Flunixin meglumin555322311
Jun 19 2018 Flunixin meglumin56565213
Jun 19 2018 Flunixin meglumin53555212
Jun 19 2018 Flunixin meglumin56562313
Jun 19 2018 Flunixin meglumin5222212
Jun 19 2018 Flunixin meglumin52529
Jun 19 2018 Flunixin meglumin457456412
Jun 19 2018 Flunixin meglumin56+5656511

return back

Copyright © 2012-2017 toextrade Inc. All rights reserved. Contact us